NCT06331000View on ClinicalTrials.gov

Effect of One Year Elexacaftor-tezacaftor-ivacaftor Treatment

CompletedOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

February 20, 2025

Study Completion Date

February 24, 2025

Conditions
Cystic Fibrosis
Interventions
DRUG

elexacaftor-tezacaftor-ivacaftor treatment

Effect of one year elexacaftor-tezacaftor-ivacaftor treatment on glucose tolerance abnormalities in adult patients with cystic fibrosis

Trial Locations (1)

67000

Hopitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT06331000 - Effect of One Year Elexacaftor-tezacaftor-ivacaftor Treatment | Biotech Hunter | Biotech Hunter